Alzheimer’s Drug Discovery Foundation and Target ALS Foundation (US). R-202203-2023090 | Machine learning for the diagnosis and multimodal profile of neurodegenerative diseases based on miRNA circulating miRNA in Latin American population | 2022-2024
Abstract: The proposed approach involves the development of a low-cost non-invasive diagnostic tool for the detection and differentiation between patients with AD, FTD, and ALS. This diagnosis is based on the interpretation and analysis of a panel of exosomal and plasma miRNAs. Using a Machine Learning algorithm based on the expression levels of these miRNAs, […]
